MannKind | MNKD - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Adma Biologics USD 408.21M 17.88M 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
Insmed USD 757.49M 52.64M 2026-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
MannKind USD -67.2M 8M 2026-06
Merck USD 41.93B 3.94B 2026-06
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Novavax USD -190.71M 45.94M 2026-06
Novo Nordisk DKK 33.81B 169.25B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Xencor USD 503.23M 12.4M 2026-06